Food effects remain one of the most challenging—and high-risk—variables in oral drug development. While increased fed-state solubility is often assumed to translate to improved absorption, real-world outcomes frequently tell a different story.
Join us for a 4-part virtual webinar series on February 10–11 (2 hours each day), where experts will explore why dissolution data alone can be misleading—and how integrated dissolution–permeation approaches provide a more clinically predictive framework for assessing food effects.
Featured guest speakers include:
- Kiyohiko Sugano, Professor, College of Pharmaceutical Sciences, Ritsumeikan University, Japan
- Gobardhan Bal, PhD, Biopharm expert, Chemical and pharmaceutical profiling, Novartis Pharma, Technical Research and Development
- Marina Statelova, PhD, Biopharm expert, Analytical R&D Data Science in Dissolution and Biopharmaceutics, Novartis Pharma, Technical Research and Development
- Enikő Borbás, Research Fellow, Budapest University of Technology and Economics
- Haotian Wang, Technical Director Asia, Pion Inc.
